Repare Therapeutics

REPARE THERAPEUTICS INC

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Repare Therapeutics Inc

Press Releases

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Repare Therapeutics Announces Leadership Transitions

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib

OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

IMNM

INSM

KURA

RPTX

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

BeyondSpring

Cibus

Cue Biopharma

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

ImmuCell

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Immix Biopharma

MiNK Therapeutics

INmune Bio

Opus Genetics

MDxHealth

Metagenomi

MediciNova

NewAmsterdam Pharma Company N.V. - Warrant

NewAmsterdam Pharma Co

OS Therapies

Ovid Therapeutics

Pyxis Oncology

Sutro Biopharma

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

HC Wainwright & Co.

Stifel

Piper Sandler

Morgan Stanley

Comments

Repare Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL